ArticlePloS one2014

Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cells.

Bruno Christian Koehler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.